Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2013
10/30/2013EP2655368A1 Compositions and methods for modulating farnesoid x receptors
10/30/2013EP2655367A1 N-substituted azetidine derivatives
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2655358A1 Oxindolopyrimidine as igf1r receptor inhibitors
10/30/2013EP2655350A1 Bicyclic pkm2 activators
10/30/2013EP2655345A1 Aryl triazole compounds with antitumoural activity
10/30/2013CN1989099B Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
10/30/2013CN103380131A Heteroaryl compounds as 5-ht4 receptor ligands
10/30/2013CN103380130A Novel pyrazole and imidazole derivatives useful as orexin antagonists
10/30/2013CN103380122A Novel benzodioxole piperazine compounds
10/30/2013CN103380117A Picolinamide inhibitors of kinases
10/30/2013CN103380112A Indole derivatives as modulators of S1P receptors
10/30/2013CN103373992A 1, 3, 4-Oxadiazole and pyridine (pyrazine) ring-containing acylhydrazone derivatives, preparation method and applications
10/30/2013CN103373985A 杂环化合物及其用途 Heterocyclic compounds and their use
10/30/2013CN103373971A Urea compounds serving as protein kinase inhibitors
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102066360B Quinoline or isoquinoline substituted P2X7 antagonists
10/30/2013CN101821259B Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in field of blood coagulation
10/30/2013CN101506180B Human protein tyrosine phosphatase inhibitors and methods of use
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569511 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569307 Indole compounds as an inhibitor of cellular necrosis
10/29/2013US8569302 Inhibitors of flaviviridae viruses
10/29/2013US8569299 Prolylcarboxypeptidase inhibitors
10/29/2013US8569297 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
10/29/2013US8569296 PI3K (delta) selective inhibitors
10/29/2013US8569292 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
10/29/2013US8569281 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK
10/29/2013CA2563038C Neurologically-active compounds
10/24/2013WO2013157022A1 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
10/24/2013WO2013156936A1 Process for the preparation of rivaroxaban and intermediates thereof
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013156272A1 Triazine derivatives
10/24/2013WO2013156005A1 Method of preparing potassium salt of azilsartan medoxomil of high purity
10/24/2013WO2012136080A8 Benzomorpholine derivatives, preparation method and use thereof
10/24/2013US20130281708 Process for the Production of 2-Amino-5-Fluorothiazole
10/24/2013US20130281692 Triazine derivatives
10/24/2013US20130281691 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
10/24/2013US20130281690 Isoxazolo-pyridine derivatives
10/24/2013US20130281499 Compounds
10/24/2013US20130281492 Novel oxazolidinone derivatives
10/24/2013US20130281452 Substituted 4-aminobenzamides as kcnq2/3 modulators
10/24/2013US20130281449 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
10/24/2013US20130281432 Pyridinones/pyrazinones, method of making, and method of use thereof
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281428 Pyridone Derivatives
10/24/2013US20130281426 Pyridazinones, the preparation method and the use thereof
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2651932A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651928A2 Anti-viral compounds
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651901A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
10/23/2013EP2651889A1 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
10/23/2013EP2651226A1 Herbicidal compositions
10/23/2013CN103370315A Compositions and methods for modulating farnesoid x receptors
10/23/2013CN103370067A Novel oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/23/2013CN103370065A Novel benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/23/2013CN103360382A Quinazoline derivative and application thereof
10/23/2013CN103360381A New crystal form of Azilsartan, and preparation method and application thereof
10/23/2013CN103360380A Synthesis method of rivaroxaban, and rivaroxaban intermediate and preparation thereof
10/23/2013CN103360379A Novel oxazolidinone compound
10/23/2013CN103360378A Synthesis of oxadiazole derivatives and application of oxadiazole derivatives in field of antibacterial drugs
10/23/2013CN103360377A A compound used for a dye
10/23/2013CN102548988B Azilsartan organic amine salts, preparation method and use thereof
10/23/2013CN102276594B Iloperidone medicinal cocrystal and preparation method thereof
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/22/2013US8563746 Cyclic benzimidazole derivatives useful as anti-diabetic agents
10/22/2013US8563741 CDK inhibitors containing a zinc binding moiety
10/22/2013US8563567 Substituted heterocyclic compounds
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563565 Pyrazoloquinoline derivatives
10/22/2013US8563549 Pyrimidine derivatives used as PI-3 kinase inhibitors
10/22/2013US8563540 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013CA2613047C Method of synthesis of azole-containing amino acids
10/22/2013CA2580150C Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154303A1 Pyrimidine derivative substituted with novel hydrazine, and use thereof
10/17/2013WO2013154080A1 Aryloxyurea compound and pest control agent
10/17/2013WO2013152741A1 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
10/17/2013WO2013124748A4 Novel polymorphs of azilsartan medoxomil potassium
10/17/2013US20130274469 Isoxazolo-pyridine derivatives
10/17/2013US20130274468 Isoxazolo-pyridine derivatives
10/17/2013US20130274467 Isoxazolo-pyridine derivatives
10/17/2013US20130274464 Arylethynyl Derivatives
10/17/2013US20130274299 Cognition Enhancing Compounds and Compositions, Methods of Making, and Methods of Treating
10/17/2013US20130274283 Premature-termination-codons readthrough compounds
10/17/2013US20130274275 4-phenylamino-quinazolin-6-yl-amides
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274242 Substituted pyrimidine compounds and their use as syk inhibitors
10/17/2013US20130274174 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
10/17/2013US20130273569 Violet laser excitable dyes and their method of use
10/17/2013US20130273004 Substituted alkylamine derivatives and methods of use
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 647